Protagenic Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal …

Biotechnology
US, New York [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Protagenic Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Protagenic Therapeutics, Inc. has no acquisition track records yet.

End of PTIX's Analysis
CIK: 1022899 CUSIP: 74365N103 ISIN: US74365N2027 LEI: - UEI: -
Secondary Listings
PTIX has no secondary listings inside our databases.